Pharmacodynamic Response of the MET/HGF-Receptor to Small Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays

PURPOSE: Rational development of targeted MET inhibitors for cancer treatment requires a quantitative understanding of target pharmacodynamics, including molecular target engagement, mechanism of action, and duration of effect. METHODS: Sandwich immunoassays and specimen-handling procedures were dev...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Cancer Res
Egile Nagusiak: Srivastava, Apurva K, Hollingshead, Melinda G., Weiner, Jennifer, Navas, Tony, Evrard, Yvonne A., Khin, Sonny, Ji, Jiuping, Zhang, Yiping, Borgel, Suzanne, Pfister, Thomas D, Kinders, Robert J., Bottaro, Donald P, Linehan, W Marston, Tomaszewski, Joseph E, Doroshow, James H, Parchment, Ralph E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7802886/
https://ncbi.nlm.nih.gov/pubmed/27001313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-2323
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak